BackOmeros Overview
Omeros Corporation

Omeros Target Price

Where could OMER trade next? Consensus target price: $22.

Get informed when a big investor buys or sells

+ Follow

Share Price

$17.99

Average Target Price

$22.0022.3% upside

1 analysts in the last 4 months

High: $22 | Low: $22

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-22Cantor FitzgeraldOlivia Brayer Saunders$2222.3% upsideOpen
2026-06-29H.C. WainwrightBrandon Folkes$3383.4% upsideOpen
2026-01-08H.C. WainwrightBrandon Folkes$40122.3% upsideOpen
2025-10-15H.C. Wainwright$2011.2% upsideOpen
2025-06-27H.C. WainwrightBrandon Folkes$950% downsideOpen
2022-12-08UBS$288.9% downsideOpen

Omeros (OMER) FAQ

Omeros (OMER) currently reports a target price of $22. Use the charts on this page to explore Omeros's target price history and peer comparisons.

Analysts' average 12-month price target for Omeros is $22, about 22.3% upside from the current share price of $17.99. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $22, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Omeros, and consider following OMER for alerts when major investors trade the stock.

Omeros is classified in the Healthcare sector. On target price, it currently shows $22. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OMER with unrelated industries.